TAK
Takeda Pharmaceutical Company Limited
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · JP
$18.45
−1.39%0
Insider buys (3m)
19
Insider sells (3m)
-$12.4M
Net value (3m)
+18.7%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 3, 2026 | Plump Andrew Stewart · director, officer: President, R&D | Sale | 116,191 | $18 |
| Aug 21, 2026 | Plump Andrew Stewart · director, officer: President, R&D | Sale | 19,651 | $18 |
| Aug 19, 2026 | Greenway Nicola Deidre Petal · officer: Chief Human Resources Officer | Sale | 12,980 | $18 |
| Aug 12, 2026 | Platford Giles Richard · officer: President, IBU | Sale | 31,083 | $17 |
| Aug 12, 2026 | Shannon Elaine Mary · officer: Pres., Global Supply & Quality | Sale | 3,978 | $17 |
| Aug 12, 2026 | Kim Julie So-Young · director, officer: President and CEO | Sale | 89,090 | $17 |
| Aug 12, 2026 | Greenway Nicola Deidre Petal · officer: Chief Human Resources Officer | Sale | 6,774 | $17 |
| Aug 12, 2026 | Ricci Gabriele · officer: Chief Data & Tech. Officer | Sale | 25,088 | $17 |
| Aug 12, 2026 | Greenway Nicola Deidre Petal · officer: Chief Human Resources Officer | Sale | 33,628 | $18 |
| Aug 12, 2026 | Farajallah Awny Samaan Botros · officer: Chief Medical Officer | Sale | 14,006 | $17 |
| Aug 12, 2026 | Ibrahim Ramy Riad Ahmed · officer: President, PDT BU | Sale | 7,277 | $17 |
| Aug 12, 2026 | Pacheco Rhonda Janice · officer: President, U.S. Business Unit | Sale | 16,901 | $17 |
| Aug 12, 2026 | Duprey Lauren Rusckowski · officer: Chief Transformation Officer | Sale | 47,586 | $17 |
| Aug 12, 2026 | Plump Andrew Stewart · director, officer: President, R&D | Sale | 165,393 | $17 |
| Aug 12, 2026 | Pignagnoli Agosti Marcello · officer: Head, Strat. & Port. Dev | Sale | 22,957 | $17 |
| Aug 12, 2026 | Greenway Nicola Deidre Petal · officer: Chief Human Resources Officer | Sale | 975 | $18 |
| Aug 12, 2026 | Bitetti Teresa Marie · officer: President, OBU | Sale | 50,012 | $17 |
| Aug 12, 2026 | Shannon Elaine Mary · officer: Pres., Global Supply & Quality | Sale | 20,363 | $18 |
| Aug 12, 2026 | Furney Natalie Anne Marie · officer: Global General Counsel | Sale | 30,868 | $17 |
| Jul 6, 2026 | Miyabashira Asuka · officer: President, Japan Pharma B.U. | A-Award | 666 | $0.00 |
| Jul 6, 2026 | Furuta Milano · director, officer: Chief Financial Officer | A-Award | 12,300 | $0.00 |
| Jul 6, 2026 | Furuta Milano · director, officer: Chief Financial Officer | A-Award | 4,288 | $0.00 |
| Jul 6, 2026 | Platford Giles Richard · officer: President, IBU | A-Award | 49,558 | $0.00 |
| Jul 6, 2026 | Smoter Jennifer Marie · officer: Chief Comm. & Gov. Officer | A-Award | 18,808 | $0.00 |
| Jul 6, 2026 | Ibrahim Ramy Riad Ahmed · officer: President, PDT BU | A-Award | 25,078 | $0.00 |
| Jul 6, 2026 | Greenway Nicola Deidre Petal · officer: Chief Human Resources Officer | A-Award | 22,570 | $0.00 |
| Jul 6, 2026 | Farajallah Awny Samaan Botros · officer: Chief Medical Officer | A-Award | 17,554 | $0.00 |
| Jul 6, 2026 | Furney Natalie Anne Marie · officer: Global General Counsel | A-Award | 43,886 | $0.00 |
| Jul 6, 2026 | Pacheco Rhonda Janice · officer: President, U.S. Business Unit | A-Award | 50,156 | $0.00 |
| Jul 6, 2026 | Pignagnoli Agosti Marcello · officer: Head, Strat. & Port. Dev. | A-Award | 27,586 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 127Increased 314Reduced 167Sold out 41
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Capital Research Global Investors | Increased | 19,297,680 | Aug 12, 2026 |
| CAPITAL RESEARCH GLOBAL INVESTORS | Increased | 19,104,219 | May 13, 2026 |
| FMR LLC | Increased | 9,599,302 | Aug 13, 2026 |
| FMR LLC | Increased | 7,117,486 | May 15, 2026 |
| MORGAN STANLEY | Increased | 6,994,924 | Aug 13, 2026 |
| MORGAN STANLEY | Reduced | 6,469,600 | May 15, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | New Position | 6,424,984 | May 15, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Reduced | 6,050,771 | Aug 14, 2026 |
| GOLDMAN SACHS GROUP INC | Reduced | 5,618,728 | May 15, 2026 |
| GOLDMAN SACHS GROUP INC | Reduced | 5,125,032 | Aug 14, 2026 |
| GOLDMAN SACHS GROUP INC | Reduced | 4,805,235 | Mar 25, 2026 |
| BRANDES INVESTMENT PARTNERS, LP | Increased | 4,539,347 | Aug 14, 2026 |
| BRANDES INVESTMENT PARTNERS, LP | Increased | 4,430,642 | May 15, 2026 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | Increased | 3,732,924 | Aug 13, 2026 |
| BlackRock, Inc. | Increased | 3,688,166 | Aug 7, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 3, 2026